Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Liberty All-Star® Equity Fund Announces New Portfolio Manager
-
Freedom Holding Corp. Announces That It Has Launched an Offering of Its Common Stock
-
Aqua New Jersey President Natalie Chesko Recognized for Outstanding Achievements in Construction Industry
-
Skillsoft Announces New Employee Inducement Grant Under NYSE Rule 303A.08
-
The Children’s Place Reports First Quarter 2026 Results
-
Fox River Provides Reminder To Vote And Updated Dissent Rights
-
VistaShares BitBonds™ 5 Yr Enhanced Weekly Option Income ETF (BTYB) to Close
-
Bitmine Immersion Technologies Announces Initial Dividends and NYSE Listing for Series A Preferred Stock
-
Hotelier Robert Balzebre Opens Solei Beach Club at the Kimpton Surfcomber Hotel
-
M3-Brigade Acquisition V Corp. Announces Cancellation of Extraordinary General Meeting of Shareholders to Approve Business Combination
-
SEEM Board Meeting and Annual Meeting of Participants and Stakeholders Scheduled on June 24
-
Black Hills Corp. Requests Rate Review in Colorado
-
Invesco Mortgage Capital Inc. June 2026 Dividend Announcement and May Financial Update
-
BNY Announces Redemption of 582,500 Depositary Shares, Each Representing a 1/100th Interest in a Share of its Series H Noncumulative Perpetual Preferred Stock
-
Target Announces Voting Results from 2026 Annual Meeting of Shareholders
-
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Blackstone Credit & Insurance Closed-End Funds Declare Monthly Distributions
-
Lineage, Inc. Declares Dividend for Second-Quarter 2026
-
Coffee Holding Company Reports Second Quarter Results.
-
CXApp Inc. (NASDAQ:CXAI) Invites Shareholders to attend 2026 Annual Meeting of Shareholders
-
NewLake Capital Partners Issues Second Quarter 2026 Common Stock Dividend of $0.43 per Share
-
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With WELIREG® (belzutifan), for Adjuvant Treatment of Certain Patients With Clear Ce
-
TPG RE Finance Trust, Inc. Declares Cash Dividend on Common Stock
-
Caro Holdings Announces Asset Purchase and Framework for Acquisition of Goldrange Resources Corp
-
UID and AEG ID Combine to Expand Industrial RFID Solutions Across North America
-
Air Canada Welcomes New Collective Agreement Ratified by its Customer Service Employees
-
Data Watts Partners Inc. Provides Status Update for Filing Audited Annual Financial Statements
-
NordX Metals Closes $1.2 Million Private Placement
-
Net Lease Office Properties Announces Postponement of Annual Meeting of Shareholders
-
The NotaryCan Signing Services Earns 5-Star Recognition for Remote Online Notarization in Sanford, Florida
-
Cartesian Therapeutics Announces New Employment Inducement Grant
-
Savara Announces New Employment Inducement Grant
-
Forbright Announces Closing of Initial Public Offering
-
Irenic Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing June 18, 2026
-
Avista pauses processing of energy service request from 500 MW data center developer while seeking broader policy and community alignment
-
Avista pauses processing of energy service request from 500 MW data center developer while seeking broader policy and community alignment
-
XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date
-
Canterbury Park Holding Corporation Announces Quarterly Cash Dividend
-
4DMT Announces New Employment Inducement Grants
-
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Viewing China from Afar: The Woman Who Bridged Two Nations
-
Rhythm Pharmaceuticals to Announce Interim Six-Month Phase 2 Results Evaluating Setmelanotide in Patients with Prader-Willi Syndrome
-
Monolithic Power Systems Announces Second Quarter 2026 Dividend
-
Hemlo Mining Corp. Announces Voting Results from Annual General and Special Meeting of Shareholders
-
INTRACARE REBRANDS CLINICAL RESEARCH DIVISION AS "CAREON"
-
DELLA Highlights Growing Demand for Room-by-Room Climate Control in Southern California
-
Atara Biotherapeutics Announces Changes to Its Board of Directors
-
CryptoNewsBreaks – Beeline Holdings Inc. (NASDAQ: BLNE) Leveraging AI, Digital Infrastructure to Scale Platform
-
NYSE American to Commence Delisting Proceedings Against TechCreate Group Ltd. (TCGL)
-
NYSE American to Commence Delisting Proceedings Against JM Group Limited (JMG)
